TITLE

A Study on Assessment and Comparison of Anti Diabetic effect of Monotherapy and Combination Therapy involving in Metformine and Glimipride

AUTHOR(S)
Saravanan, K.; Manna, P. K.; Mohanta, G. P.
PUB. DATE
January 2014
SOURCE
Journal of Pharmaceutical Sciences & Research;2014, Vol. 6 Issue 1, p11
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Diabetes mellitus (DM) is a complex metabolic disorder and which is one of the major health crisis the world facing today. There is no permanent cure for DM, however. It could be managed successfully with existing oral hypoglycaemic agents and insulin. Most of the time diabetic management will be unsuccessful in outpatients because of lack of health consciousness of the patients leading to noncompliance of advises given by physician and pharmacist. The main objective of the present study was to monitor three groups of Type-2 DM patients through frequent patient counselling and plasma glucose level monitoring using commercial self monitoring blood glucometer (SMBG). Patients were advised to take single or combination of Metformine or Glimipride for up to 24 weeks. Blood glucose levels were assessed at fasting and post prandial condition using SMBG. The results indicate that both single and combination therapy significantly reduces the DM complications. However the combination therapy provided better improvement of DM complications as compare to single drug treatment. More drugs related adverse effects were observed in combination therapy. The study reveals that the better clinical patient compliance of diabetic management could be achieved with proper and frequent patient counselling.
ACCESSION #
93607437

 

Related Articles

  • Metformin Augments Levels of Molecules that Regulate GLUT4 in Endometria.  // Fertility Weekly;1/6/2014, p5 

    The article presents a study to find whether the metabolic-endocrine hyperinsulinemic polycystic ovary syndrome (PCOS-h-INS) in women, can be controlled with alterations in the molecule levels of proteins that regulate expression of insulin-dependent glucose transporter (GLUT4). Metformin...

  • Obesity: a risk factor for cancer. King, Brad J. // Alive: Canada's Natural Health & Wellness Magazine;Apr2006, Issue 282, p34 

    The article discusses the association of obesity and cancer. Accumulation of body fat is connected with high insulin levels that known as hyperinsulinemia. Hyperinsulinemia is found to increase the incidence of obesity on prepubescent girls. Many forms of cancer are also associated with high...

  • HEART FAILURE.  // Heart;Dec2006, Vol. 92 Issue 12, p1887 

    The article focuses on the used of ultrasonic backscatter analysis to examine subclinical alterations of left ventricular (LV) structure and function in severe obesity. Insulin resistance of the patients was assessed. It was found that obese patients have a greater LV mass index by height than...

  • The role of adding metformin in insulin-resistant diabetic pregnant women: a randomized controlled trial. Ibrahim, Moustafa; Hamdy, Ahmed; Shafik, Adel; Taha, Salah; Anwar, Mohammed; Faris, Mohammed // Archives of Gynecology & Obstetrics;May2014, Vol. 289 Issue 5, p959 

    Purpose: The aim of the present study is to assess the impact of adding oral metformin to insulin therapy in pregnant women with insulin-resistant diabetes mellitus. Methods: The current non-inferiority randomized controlled trial was conducted at Ain Shams University Maternity Hospital. The...

  • Meeting glycemic goals: Options beyond metformin. DeBenederte, Valerie // Drug Topics;Nov2012 Supplement, p8s 

    The article discusses the options in drug treatment for type 2 diabetes patients beyond the use of metformin in controlling glycemic and glycosylated hemoglobin (HbA1c) levels. Clinical professor Stefanie C. Nigro explains that approaches in diabetes management and patient care plan may differ...

  • Fatty Acid Translocase (FAT/CD36) Is Localized on Insulin-Containing Granules in Human Pancreatic β-Cells and Mediates Fatty Acid Effects on Insulin Secretion. Noushmehr, Houtan; D'Amico, Eugenio; Farilla, Loredana; Hui, Hongxiang; Wawrowsky, Kolja A.; Mlynarski, Wojciech; Doria, Alessandro; Abumrad, Nada A.; Perfetti, Riccardo // Diabetes;Feb2005, Vol. 54 Issue 2, p472 

    The membrane receptor FAT/CD36 facilitates the major fraction of long-chain fatty acid (FA) uptake by muscle and adipose tissues. In line with the well-known effects of FA metabolism on carbohydrate utilization and insulin responsiveness, altered expression of CD36 has been linked to phenotypic...

  • Metformin does not attenuate the acute insulin-sensitizing effect of a single bout of exercise in individuals with insulin resistance. Ortega, Juan; Hamouti, Nassim; Fernández-Elías, Valentín; Prada, María; Martínez-Vizcaíno, Vicente; Mora-Rodríguez, Ricardo // Acta Diabetologica;Oct2014, Vol. 51 Issue 5, p749 

    Combining metformin and exercise is recommended for the treatment of insulin resistance. However, it has been suggested that metformin blunts the insulin-sensitizing effects of exercise. We evaluated in a group of insulin-resistant patients the interactions between exercise and their daily dose...

  • Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial. B. Trolle; A. Flyvbjerg; U. Kesmodel; F.F. Lauszus // Human Reproduction;Nov2007, Vol. 22 Issue 11, p2967 

    BACKGROUND Our aim was to assess the effects of metformin on menstrual frequency, fasting plasma glucose (FPG), insulin resistance assessed as HOMA-index, weight, waist/hip ratio, blood pressure (BP), serum lipids, and testosterone levels in women with polycystic ovary syndrome (PCOS) METHODS...

  • Recovery Studies on Metformin Hydrochloride and Gliclazide Combined Dosage Form (Tablets) Using Rp-Hplc Techniques. Saha, Dibyajyoti; Paul, Swati // International Journal of Pharmacy Teaching & Practices (IJPTP);Dec2012, Vol. 3 Issue 4, p405 

    Metformin hydrochloride is 1, 1-dimethyl biguanide hydrochloride and is also a hypoglecaemic drug. Gliclazide, is a third generation sulphonyl urea class hypoglycaemic drug which acts via stimulating β- cells of the isleta of langerhans of pancreas to release insulin. Metformin HCL differs...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics